Metastatic or Unresectable Melanoma
Oncology·MeSH: Neoplasm Metastasis
Prevalence
75.0 / 100K
Incidence
23.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Metastatic or Unresectable Melanoma?
There are 1 clinical trial targeting Metastatic or Unresectable Melanoma tracked by BioSniper.
What is the prevalence of Metastatic or Unresectable Melanoma?
The estimated prevalence of Metastatic or Unresectable Melanoma is approximately 75.0 per 100,000 population.
Deep-dive into Metastatic or Unresectable Melanoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis